RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$6.38
−2.52%0
Insider buys (3m)
4
Insider sells (3m)
-$118.0K
Net value (3m)
+27.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Weinberg Eric · officer: See remarks | M-Exempt | 5,370 | $0.00 |
| Sep 2, 2026 | Weinberg Eric · officer: See remarks | Sale | 2,041 | $6.96 |
| Sep 2, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | Sale | 2,041 | $6.96 |
| Sep 2, 2026 | Kurtz Ronald M MD · officer: Chief Medical Officer | M-Exempt | 13,425 | $0.00 |
| Sep 2, 2026 | Kurtz Ronald M MD · officer: Chief Medical Officer | Sale | 5,100 | $6.96 |
| Sep 2, 2026 | Wilterding Mark · officer: Chief Financial Officer | M-Exempt | 20,441 | $0.00 |
| Sep 2, 2026 | Wilterding Mark · officer: Chief Financial Officer | Sale | 7,765 | $6.96 |
| Sep 2, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | M-Exempt | 5,370 | $0.00 |
| Jul 24, 2026 | Mottiwala Aziz · director, officer: President and CEO | A-Award | 2,312,138 | $0.00 |
| Jul 24, 2026 | Mottiwala Aziz · director, officer: President and CEO | A-Award | 571,286 | $5.19 |
| Jun 18, 2026 | Fountain Tamara · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | Andrews Julie · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | Tammenoms Bakker Juliet · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | COHEN RAYMOND W · director | A-Award | 30,864 | $0.00 |
| Jun 18, 2026 | Corley Jesse Anderson · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | Warner Robert Keith · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | PALMISANO ROBERT J · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | Maniar Shweta · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | LINK WILLIAM J PHD · director | A-Award | 37,037 | $0.00 |
| Apr 20, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | M-Exempt | 12,489 | $4.13 |
| Mar 3, 2026 | Kurtz Ronald M MD · director, officer: President & CEO | A-Award | 80,545 | $0.00 |
| Mar 3, 2026 | Gaines Scott · officer: Chief Customer Officer | M-Exempt | 1,657 | $0.00 |
| Mar 3, 2026 | Gaines Scott · officer: Chief Customer Officer | M-Exempt | 604 | $0.00 |
| Mar 3, 2026 | Wilterding Mark · officer: Chief Financial Officer | M-Exempt | 20,441 | $0.00 |
| Mar 3, 2026 | Wilterding Mark · officer: Chief Financial Officer | F-InKind | 8,068 | $7.61 |
| Mar 3, 2026 | Gaines Scott · officer: Chief Customer Officer | M-Exempt | 6,261 | $0.00 |
| Mar 3, 2026 | Gaines Scott · officer: Chief Customer Officer | A-Award | 32,218 | $0.00 |
| Mar 3, 2026 | Gaines Scott · officer: Chief Customer Officer | M-Exempt | 1,250 | $0.00 |
| Mar 3, 2026 | Gaines Scott · officer: Chief Customer Officer | F-InKind | 2,580 | $7.61 |
| Mar 3, 2026 | Gaines Scott · officer: Chief Customer Officer | M-Exempt | 1,500 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 33Increased 66Reduced 55Sold out 161
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 3,187,092 | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 2,059,459 | May 15, 2026 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | Reduced | 2,058,684 | May 13, 2026 |
| NOMURA HOLDINGS INC | Unchanged | 2,000,060 | May 15, 2026 |
| NO STREET GP LP | Increased | 2,000,000 | May 15, 2026 |
| D. E. SHAW & CO., INC. | Increased | 1,959,732 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,692,935 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 1,300,260 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 1,210,039 | May 18, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,170,919 | May 15, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | Increased | 1,131,400 | May 14, 2026 |
| FEDERATED HERMES, INC. | Increased | 1,080,712 | May 11, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Increased | 1,066,321 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,019,127 | May 13, 2026 |
| DEUTSCHE BANK AG\ | Increased | 962,312 | May 6, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026